Myelodysplastic syndromes

00:00 / 00:00



Myelodysplastic syndromes


Coagulation disorders


Vitamin K deficiency

Leukemoid reaction

Leukemoid reaction


Myelodysplastic syndromes


0 / 11 complete

USMLE® Step 1 questions

0 / 1 complete

High Yield Notes

10 pages


Myelodysplastic syndromes

of complete


USMLE® Step 1 style questions USMLE

of complete

A 65-year-old woman comes to the clinic because of shortness of breath and fatigue for the past 2 months. The patient states that she feels tired all day and has little energy to get out of bed. She also reports frequently stopping to catch her breath after climbing a flight of stairs. Past medical history is significant for breast cancer treated with chemoradiotherapy 10 years ago. Family history is noncontributory. Temperature is 37.0°C (98.6°F), pulse is 101/min, respirations are 20/min, and blood pressure is 135/85 mmHg. Physical examination shows mucosal pallor but no lymphadenopathy. Laboratory evaluation reveals:  
 Laboratory value  Result 
 Complete blood count 
 Hemoglobin   8.0 g/dL 
 Platelet count   70,000/mm3 
 Leukocyte count   16,100/mm3 

Peripheral blood smear is shown below:  

Reproduced from: Wikimedia Commons
Which of the following is the most likely diagnosis in this patient?

External References

First Aid








Acute myelogenous leukemia (AML) p. 440

myelodysplastic syndromes p. 438


myelodysplastic syndromes p. 439


myelodysplastic syndromes p. 439

Myelodysplastic syndromes p. 439

sideroblastic anemia p. 427

Radiation exposure

myelodysplastic syndromes p. 439

Stem cells

myelodysplastic syndromes and p. 440


Content Reviewers

Myelodysplastic syndromes, or MDS, are a group of rare blood disorders associated with faulty development of blood cells in the bone marrow.

MDS can affect individuals of all ages, but it’s more common after the age of 60.

Blood cells develop from hematopoietic stem cells, through a process called hematopoiesis.

This involves a number of divisions, and eventually, results in three types of blood cells: red blood cells, which carry oxygen around our bodies, white blood cells to help fight disease causing pathogens, and platelets that help form clots to stop bleeding.

Once these cells are fully mature, they leave the bone marrow and enter the bloodstream.

In MDS, hematopoietic stem cells are damaged, so they give rise to faulty blood cells, which don’t mature, but instead persist as immature cells, called blasts.

These immature blood cells usually die in the bone marrow or soon after they go into the blood, so you can’t really count on them to do the job of mature blood cells.

As the condition progresses, immature blood cells gradually take over the bone marrow, which displaces and reduces the normal ones.

In most cases, the cause of MDS is not known.

When this happens, it's classified as primary MDS.

In rare cases, they can be caused by chemo or radiation therapy, and this is called secondary MDS.

MDS comprises a spectrum of diseases with differing potential for remaining stable or progressing to acute myeloid leukemia, or AML.

The most common feature of MDS is anemia, caused by low red blood cell levels.

Symptoms of anemia include dizziness, irritability, headaches, and pale skin.

Low white blood cell levels increase the risk of bacterial and fungal infections.

Finally, low levels of platelets cause excessive bruising following minimal injury and easy bleeding.

Now, MDS usually worsens with time, as normal bone marrow function diminishes.

40-50 percent of the time, MDS deteriorates into a form of cancer known as acute myeloid leukemia, or AML.

This happens when there are more than 20% blasts in the bone marrow.

Diagnosis requires a variety of specialized tests including complete blood counts, a peripheral blood smear, as well as bone marrow aspiration and biopsy.

On a complete blood count, there may be low levels of one, two or all of the three blood cell types.

On a peripheral blood smear, there may be big and oval-shaped red blood cells and abnormal white blood cells and platelets.


Myelodysplastic syndromes or just MDS, refer to a group of disorders in which the bone marrow does not produce enough healthy blood cells, usually for unknown causes. Symptoms can include fatigue, shortness of breath, and an increased risk of infection and bleeding. Treatment options for MDS include medications, transfusions, and bone marrow transplantation, depending on the severity of the condition.


  1. "Harrison's Principles of Internal Medicine" McGraw Hill Education/ Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Red blood cell morphology" International Journal of Laboratory Hematology (2013)
  7. "Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review" Hematology (2020)

Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.